KR101295733B1 - 혈액암의 치료방법 및 조성물 - Google Patents

혈액암의 치료방법 및 조성물 Download PDF

Info

Publication number
KR101295733B1
KR101295733B1 KR1020077006358A KR20077006358A KR101295733B1 KR 101295733 B1 KR101295733 B1 KR 101295733B1 KR 1020077006358 A KR1020077006358 A KR 1020077006358A KR 20077006358 A KR20077006358 A KR 20077006358A KR 101295733 B1 KR101295733 B1 KR 101295733B1
Authority
KR
South Korea
Prior art keywords
cells
cva21
virus
cancer
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020077006358A
Other languages
English (en)
Korean (ko)
Other versions
KR20070083578A (ko
Inventor
고프 제프리 아유
대런 레이몬드 샤프렌
Original Assignee
비랄리틱스 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2004904766A external-priority patent/AU2004904766A0/en
Application filed by 비랄리틱스 리미티드 filed Critical 비랄리틱스 리미티드
Publication of KR20070083578A publication Critical patent/KR20070083578A/ko
Application granted granted Critical
Publication of KR101295733B1 publication Critical patent/KR101295733B1/ko
Assigned to 머크 샤프 앤드 돔 코포레이션 reassignment 머크 샤프 앤드 돔 코포레이션 권리의 전부이전등록 Assignors: 비랄리틱스 리미티드
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/768—Oncolytic viruses not provided for in groups A61K35/761 - A61K35/766
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
KR1020077006358A 2004-08-20 2005-08-22 혈액암의 치료방법 및 조성물 Expired - Lifetime KR101295733B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2004904766 2004-08-20
AU2004904766A AU2004904766A0 (en) 2004-08-20 Treatment for hematologic cancers
AU2005901879 2005-04-14
AU2005901879A AU2005901879A0 (en) 2005-04-14 Methods and compositions for treatment of hematologic cancers
PCT/AU2005/001257 WO2006017914A1 (en) 2004-08-20 2005-08-22 Methods and compositions for treatment of hematologic cancers

Publications (2)

Publication Number Publication Date
KR20070083578A KR20070083578A (ko) 2007-08-24
KR101295733B1 true KR101295733B1 (ko) 2013-08-13

Family

ID=35907185

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077006358A Expired - Lifetime KR101295733B1 (ko) 2004-08-20 2005-08-22 혈액암의 치료방법 및 조성물

Country Status (6)

Country Link
US (3) US8236298B2 (https=)
EP (1) EP1793851B1 (https=)
JP (2) JP5054522B2 (https=)
KR (1) KR101295733B1 (https=)
CA (1) CA2577692C (https=)
WO (1) WO2006017914A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2577692C (en) * 2004-08-20 2014-05-06 Viralytics Limited Methods and compositions for treatment of hematologic cancers
EP2125032A4 (en) 2007-02-20 2011-02-23 Mayo Foundation CANCER TREATMENT WITH VIRAL NUCLEIC ACID
WO2009139921A2 (en) * 2008-05-16 2009-11-19 Genelux Corporation Microorganisms for preventing and treating neoplasms accompanying cellular therapy
CA2915397A1 (en) * 2013-06-17 2014-12-24 Viralytics Limited Methods for the treatment of bladder cancer
WO2015127501A1 (en) * 2014-02-27 2015-09-03 Viralytics Limited Combination method for treatment of cancer
EP3064207B1 (en) * 2015-03-04 2017-12-20 Scandion Oncology A/S 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives for use as BCRP inhibitors in therapeutic treatments
RU2749050C2 (ru) 2016-01-27 2021-06-03 Онкорус, Инк. Онколитические вирусные векторы и их применение
US20190202886A1 (en) * 2016-05-11 2019-07-04 Ohio State Innovation Foundation ONCOLYTIC VIRUSES COMPRISING esRAGE AND METHODS OF TREATING CANCER
RU2021127872A (ru) 2016-06-30 2021-11-09 Онкорус, Инк. Доставка терапевтических полипептидов посредством псевдотипированных онколитических вирусов
AU2018306455A1 (en) 2017-07-26 2020-02-27 Virogin Biotech Canada Ltd Oncolytic viral vectors and uses thereof
US11865081B2 (en) 2017-12-29 2024-01-09 Virogin Biotech Canada Ltd. Oncolytic viral delivery of therapeutic polypeptides
CA3207359A1 (en) 2021-02-05 2022-08-11 Cecile Chartier-Courtaud Adjuvant therapy for cancer
JP2023085151A (ja) * 2021-12-08 2023-06-20 株式会社八神製作所 体外ホウ素中性子反応を用いた幹細胞の分取方法
EP4724111A2 (en) * 2023-06-08 2026-04-15 The Trustees Of Columbia University In The City Of New York Intracellular delivery of therapeutic cargos and viral rnas by engineered salmonella

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019380A2 (en) 1999-09-17 2001-03-22 Pro-Virus, Inc. Oncolytic virus
WO2001037866A1 (en) 1999-11-25 2001-05-31 The University Of Newcastle Research Associates Limited A method of treating a malignancy in a subject and a pharmaceutical composition for use in same
KR20060131975A (ko) * 2004-03-11 2006-12-20 바이로타르그 피티와이 엘티디 변형된 종양 용해 바이러스

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004202292B2 (en) 1999-11-25 2007-06-14 Viralytics Limited Method of Treating a Malignancy in a Subject
HK1052950B (en) 2000-06-26 2005-06-24 Wellstat Biologics Corporation Purging of cells using viruses
EP1385466B1 (en) 2001-05-11 2011-03-09 Wellstat Biologics Corporation Oncolytic virus therapy
AU2002953436A0 (en) 2002-12-18 2003-01-09 The University Of Newcastle Research Associates Limited A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis
TWI234446B (en) * 2004-04-06 2005-06-21 Wilmart Co Ltd Adjustable body-fitted sleeping bag
CA2577692C (en) * 2004-08-20 2014-05-06 Viralytics Limited Methods and compositions for treatment of hematologic cancers

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019380A2 (en) 1999-09-17 2001-03-22 Pro-Virus, Inc. Oncolytic virus
WO2001037866A1 (en) 1999-11-25 2001-05-31 The University Of Newcastle Research Associates Limited A method of treating a malignancy in a subject and a pharmaceutical composition for use in same
KR20060131975A (ko) * 2004-03-11 2006-12-20 바이로타르그 피티와이 엘티디 변형된 종양 용해 바이러스

Also Published As

Publication number Publication date
US20150273002A1 (en) 2015-10-01
KR20070083578A (ko) 2007-08-24
US20130164330A1 (en) 2013-06-27
JP5054522B2 (ja) 2012-10-24
JP2008510685A (ja) 2008-04-10
US8236298B2 (en) 2012-08-07
WO2006017914A1 (en) 2006-02-23
EP1793851B1 (en) 2016-10-05
EP1793851A4 (en) 2009-07-01
CA2577692A1 (en) 2006-02-23
EP1793851A1 (en) 2007-06-13
JP2012144549A (ja) 2012-08-02
CA2577692C (en) 2014-05-06
US20080193479A1 (en) 2008-08-14

Similar Documents

Publication Publication Date Title
US20150273002A1 (en) Methods and compositions for treatment of hematologic cancers
US8722036B2 (en) Methods for treating malignancies using coxsackieviruses
US20120328575A1 (en) Modified Oncolytic Viruses
CN101065144B (zh) 治疗血液癌症的方法和组合物
AU2005274617B2 (en) Methods and compositions for treatment of hematologic cancers
AU2004202292B2 (en) Method of Treating a Malignancy in a Subject
HK1100356B (en) Methods and compositions for treatment of hematologic cancers
AU770517B2 (en) A method of treating a malignancy in a subject and a pharmaceutical composition for use in same
AU2011204997A1 (en) A method of treating a malignancy in a subject and a pharmaceutical composition for use in same
AU2007211890A1 (en) A method of treating a malignancy in a subject and a pharmaceutical composition for use in same

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20070320

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20100820

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20120711

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20130529

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20130806

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20130807

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20160720

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20160720

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20170719

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20170719

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20180718

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20180718

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20190624

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20190624

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20200624

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20230626

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20240624

Start annual number: 12

End annual number: 12